As tens of thousands of students, faculty and staff kick off a new in-person academic year on the University of Michigan’s Ann Arbor campus, a number of university COVID-19 response efforts, policies and community expectations are in place for a productive and healthy fall term.
Here are the top things to know for the fall 2021 term:
more information
- The U-M campus community is highly vaccinated. As of Aug. 25, 91 percent of students, 88 percent of faculty and 73 percent of staff on the Ann Arbor campus were fully vaccinated. Additionally, 77 percent of Michigan Medicine employees were fully vaccinated.
- Many employees continue to work on campus in person. Others will return with the start of the fall term and still more are developing in-person work plans that are being managed at the unit level.
- Face coverings are currently required indoors in most settings on campus regardless of one’s vaccination status.
- COVID-19 vaccines are required, with limited exemptions, for all students, faculty and staff.
- All members of the U-M community coming to campus are required to use ResponsiBLUE, the daily symptom checker.
- Testing for asymptomatic COVID-19 remains available through the Community Tracking and Sampling Program for those who want it or who are required to test weekly.
- People should stay home if they are sick. This helps reduce the likelihood of spreading a range of infections including COVID, influenza and other illnesses.
Return to in-person work
Many units are resuming more in-person work based on their specific needs while other units are reducing campus density through hybrid work plans. Employees should continue to look to unit leadership for the latest information on their specific return to work plans and timelines.
Those who have concerns about returning to work should speak with their supervisors.
Face coverings required indoors
Under the latest U-M face-covering policy, all students, staff, faculty and visitors must wear a face covering that covers their mouth and nose while indoors and on U-M transportation, regardless of vaccination status.
The university policy cites limited exceptions in which a person is not required to wear a face covering indoors, including while alone in a single, enclosed, private office with the door closed; while actively eating or drinking; or while receiving a health care service that requires them to temporarily take off their face covering.
A key exception to the policy allows for vaccinated students living on campus to not wear a face covering while in their own residence hall, including common areas.
COVID-19 vaccine required
All students, faculty and staff are required to submit proof of their COVID-19 vaccination or request an exemption by Aug. 30 under the U-M COVID-19 Vaccination Policy.
Vaccines are available through Michigan Medicine, University Health Service and Occupational Health Services.
On Aug. 23, the U.S. Food and Drug Administration granted full approval to the Pfizer/BioNTech COVID-19 vaccine for people ages 16 and older. University officials said they hoped this action will further motivate unvaccinated individuals in the U-M community who had been hesitant to get vaccinated to now get vaccinated.
Advisers are available to speak with individuals with questions about the vaccine’s safety and the role of vaccination in personal and community health.
While breakthrough infections — positive tests among those vaccinated — occur with every vaccine, health officials say vaccines reduce the risk of infection and greatly reduce the likelihood of severe illness, even with the current delta variant.
The university is providing limited exemptions to its COVID-19 Vaccination Policy for medical or religious reasons. Responses to those who requested an exemption are being sent this week and on an ongoing basis as exemptions are reviewed.
Policy compliance
Employees and students who do not report their vaccination information or obtain an exemption as required under the university’s COVID-19 Vaccination Policy will be subject to a number of interventions and administrative actions.
All individuals who are not fully vaccinated by Aug. 30 will be required to get tested weekly for COVID-19 until they are fully vaccinated.
Beginning Aug. 30, non-compliant employees will be subject to disciplinary action, which will be carried out using a two-step process at the unit level. The first step will focus on further education about the policy and the vaccine, and will include a verbal warning. Michigan Medicine is following a separate process.
Supervisors can check ResponsiBLUE screens for compliance with the vaccination mandate. Reports will be made available after Aug. 27 for unit leadership to follow up with any employee out of compliance.
Additional details are available online at myumi.ch/QAd4E.
COVID-19 testing
Testing for asymptomatic COVID-19 remains available through the Community Tracking and Sampling Program for those who want it or are required to test weekly.
Weekly testing is required for individuals who have received a medical or religious exemption under the vaccine policy, as well as for those who have started their vaccination series but are not yet considered fully vaccinated.
The weekly testing requirement will be waived for those individuals who received an exemption and who are in fully remote situations, but it is expected that those individuals be tested within the previous week if they come to campus for any reason. ResponsiBLUE will track compliance with weekly testing for all students and employees granted vaccine exemptions, even those usually in a fully remote arrangement.
Individuals with symptoms of COVID-19 or a close-contact exposure should contact Occupational Health Services for faculty and staff, or University Health Service for students.
Guidance for facilities and events
U-M’s Environment, Health and Safety has updated its guidelines to minimize risks in campus operations, including distancing, cleaning protocols and events.
Currently, there is no physical distancing requirement in U-M facilities. Unvaccinated individuals should continue to practice 6 feet of distancing from others in addition to wearing a face covering.
Units are no longer under capacity restrictions for in-person events. Units should continue to request approval of events through their leadership and should strive to plan events utilizing best infection–control practices for minimizing the potential for spread of COVID-19. Those include choosing smaller gatherings over larger gatherings; using ResponsiBLUE for indoor events to indicate compliance with testing, and screening requirements; and keeping a log of names and contact information (if feasible) for attendees if case investigation and contact tracing becomes necessary.
David Blair
To make sure the Record is corrected, the FDA did NOT approve the Pfizer medical product.
There were two letters issued:
The first one regarding the existing medical product, only granted a one year extension under the EUA license.
The 2nd letter that is being used in the approval shell game is for Comirnaty. This product is not even being manufactured at this point because the usage of the similar product comes with liability.
See FDA website for these two letters.
Yi-Li Wu
David, your comments lead me to believe you have read the news reports incorrectly. In particular, I believe you have confused a couple of points:
(1) The FDA *did* officially approve the Pfizer vaccine for people aged 16 and above. Please see the press release from the FDA, here. https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine
(2) That vaccine previously did not have a name. It now has a brand name, called Comirnarty, and henceforth will be marketed as such.
(3) The FDA is still awaiting scientific results on the use of the vaccine in people 12-15 years old. While waiting, it agreed to extend the EUA that allows the vaccine to be used in people 12-15 years old, and it may also be used as a booster (third shot) in immunocompromised people. The vaccine is otherwise *approved* for use in anyone 16 years and older.
Here is the opening paragraph from the FDA’s press release of August 23, which makes all these points crystal clear:
Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.
For people who want more information, here is the page with links to the approval letters: https://www.fda.gov/vaccines-blood-biologics/comirnaty
Finally, I note that there are very few UM students, staff, and faculty who are younger than 16 years old. Since the FDA has APPROVED the vaccine for people 16 and up, the EUA (for people under 16) is not generally pertinent to UM’s vaccine mandate for students, staff, and faculty.
Lorene Sterner
Yi-Li Wu, thank you for your clarification!
Kari Dumbeck
Many reports have come out against the main stream false reporting of an “approved” “vaccine”. There is not an approved experimental gene therapy as a “vaccine” in the United States. This new drug is “authorized” only and is not used in the United States. In an interview by JFK Jr ( a lawyer) they are set to file a lawsuit against the FDA but put it on hold for this very reason. The news reports that it’s fully approved is a lie and meant to scare folks into towing the line.